Standardized FN management protocols, including broad-spectrum antibiotics and G-CSF, may rapidly correct neutropenia and reduce the clinical impact of comorbidities, thereby minimizing variation in hospitalization duration. This evidence concerns the gene CSF3 and neutropenia.